PCVX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Vaxcyte Inc

NASDAQ | PCVX

49.27

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 18, 2025)

$6.37B

Market Cap

-

P/E Ratio

-4.85

EPS

$94.76

52 Week High

$27.66

52 Week Low

HEALTHCARE

Sector

PCVX Chart

Recent Chart
Price Action

PCVX Technicals

Tags:

PCVX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$16M
Total Revenue $0
Cost Of Revenue $16M
Costof Goods And Services Sold $16M
Operating Income -$570M
Selling General And Administrative $93M
Research And Development $477M
Operating Expenses $570M
Investment Income Net -
Net Interest Income $110M
Interest Income $110M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16M
Income Before Tax -$464M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$464M
Comprehensive Income Net Of Tax -
Ebit -$464M
Ebitda -$448M
Net Income -$464M

Revenue & Profitability

Earnings Performance

PCVX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $3.5B
Total Current Assets $1.8B
Cash And Cash Equivalents At Carrying Value $388M
Cash And Short Term Investments $388M
Inventory -
Current Net Receivables $21M
Total Non Current Assets $1.7B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $1.4B
Short Term Investments $1.4B
Other Current Assets $20M
Other Non Current Assets -
Total Liabilities $205M
Total Current Liabilities $140M
Current Accounts Payable $48M
Deferred Revenue -
Current Debt -
Short Term Debt $5.9M
Total Non Current Liabilities $65M
Capital Lease Obligations $71M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $71M
Other Current Liabilities $86M
Other Non Current Liabilities $100K
Total Shareholder Equity $3.3B
Treasury Stock -
Retained Earnings -$1.4B
Common Stock $128K
Common Stock Shares Outstanding $122M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$453M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $16M
Capital Expenditures $22M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$2B
Cashflow From Financing $2.4B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$464M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$16M
Total Revenue $0
Cost Of Revenue $16M
Costof Goods And Services Sold $16M
Operating Income -$570M
Selling General And Administrative $93M
Research And Development $477M
Operating Expenses $570M
Investment Income Net -
Net Interest Income $110M
Interest Income $110M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16M
Income Before Tax -$464M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$464M
Comprehensive Income Net Of Tax -
Ebit -$464M
Ebitda -$448M
Net Income -$464M

PCVX News

PCVX Profile

Vaxcyte Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vaxcyte, Inc. (PCVX) is an innovative biotechnology leader headquartered in Foster City, California, focused on developing next-generation vaccines to combat global infectious diseases. Leveraging its proprietary technology platform, the company is advancing a diverse pipeline of vaccine candidates designed to elicit robust immune responses and address critical unmet medical needs. With a strong commitment to research and development, Vaxcyte is poised to make significant contributions towards enhancing public health and revolutionizing therapeutic strategies in the vaccine sector.

LPTX
+368.57%
$2.05
CANF
+8.28%
$0.39
ASBP
+17.08%
$0.10
NVDA
-1.66%
$183.50
WTO
-12.00%
$0.02
ONDS
+23.18%
$7.70
LOBO
+28.33%
$0.50
PLUG
+8.39%
$2.26
CHR
+1.05%
$0.04
CMND
-16.14%
$0.23
ASST
+7.21%
$1.11
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
TSLA
-1.15%
$404.18
F
+1.20%
$13.03
BITF
+4.80%
$2.79
MARA
-4.00%
$11.51
SOFI
-1.33%
$26.68
QUBT
+8.18%
$12.44
ADAP
-15.14%
$0.05
ETHD
-9.49%
$5.15
ACHR
+3.23%
$7.66
DNN
-0.20%
$2.38
CIFR
-0.06%
$14.35
WBD
+3.49%
$23.53
NIO
-2.05%
$5.95
SNAP
+1.57%
$8.30
INTC
-0.14%
$34.66
PLTR
-1.43%
$168.79
RMBL
+60.50%
$3.21
WULF
+11.84%
$12.35
BMNR
+6.05%
$32.82
LNW
-3.71%
$86.22
AAL
+0.45%
$12.39
ADD
-25.47%
$0.05
PFE
+1.53%
$25.46
AMZN
-3.94%
$223.69
AMD
-3.42%
$232.28
CAN
+18.99%
$1.01
NOK
-0.30%
$6.64
SRM
+53.27%
$10.30
GOOGL
+1.24%
$288.58
KXIN
+3.27%
$0.29
GPUS
+1.21%
$0.24
TLRY
-0.48%
$1.02
BURU
-3.94%
$0.20
ABEV
+0.02%
$2.54
HIMS
-3.78%
$35.58
RIG
+1.34%
$4.13
QBTS
-3.30%
$22.83
RUBI
+0.34%
$0.17
LFS
+55.05%
$5.98
RGTI
+3.58%
$25.57
WLGS
-5.57%
$0.04
IREN
+5.18%
$49.87
ONFO
+9.64%
$0.93
MTSR
-0.35%
$70.50
TWOH
+4.16%
$0.00
PLTD
+0.97%
$7.02
BYND
0.00%
$1.04
CRWV
+2.24%
$77.01
APLT
+2.28%
$0.29
NFLX
+3.69%
$114.36
KVUE
+0.15%
$16.26
T
+0.92%
$25.70
GRAB
-0.09%
$5.32
CGTL
-10.94%
$0.72
RIVN
+0.77%
$14.98
AAPL
+0.28%
$268.22
MU
-3.74%
$232.89
IONZ
-8.73%
$4.60
BTG
+0.27%
$4.00
EPSM
+96.22%
$2.78
AFMD
-34.94%
$0.18
BMNU
+11.98%
$8.78
CLF
+3.87%
$11.39
BBD
+0.13%
$3.62
DVLT
-4.82%
$1.77
HOOD
-0.72%
$115.13
GLMD
+1.90%
$1.07
MSFT
-2.51%
$494.70
SOUN
+1.35%
$11.58
BTBT
+4.31%
$2.39
QS
+1.51%
$13.14
YMM
-11.93%
$10.85
PLTZ
+2.14%
$7.25
MRK
+4.16%
$96.73
GOOG
+0.89%
$288.16
PR
+0.36%
$13.68
BTE
+3.48%
$3.12
VALE
+0.56%
$12.23
HPE
+0.33%
$21.30
RXRX
+1.69%
$4.18
HPQ
-6.76%
$22.87
NBIS
+7.72%
$92.62
RR
+4.34%
$3.25
AMC
+1.61%
$2.20
KDLY
-9.91%
$0.55
CLSK
+4.14%
$11.05
BAC
+0.83%
$51.91
LPTX
+368.57%
$2.05
CANF
+8.28%
$0.39
ASBP
+17.08%
$0.10
NVDA
-1.66%
$183.50
WTO
-12.00%
$0.02
ONDS
+23.18%
$7.70
LOBO
+28.33%
$0.50
PLUG
+8.39%
$2.26
CHR
+1.05%
$0.04
CMND
-16.14%
$0.23
ASST
+7.21%
$1.11
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
TSLA
-1.15%
$404.18
F
+1.20%
$13.03
BITF
+4.80%
$2.79
MARA
-4.00%
$11.51
SOFI
-1.33%
$26.68
QUBT
+8.18%
$12.44
ADAP
-15.14%
$0.05
ETHD
-9.49%
$5.15
ACHR
+3.23%
$7.66
DNN
-0.20%
$2.38
CIFR
-0.06%
$14.35
WBD
+3.49%
$23.53
NIO
-2.05%
$5.95
SNAP
+1.57%
$8.30
INTC
-0.14%
$34.66
PLTR
-1.43%
$168.79
RMBL
+60.50%
$3.21
WULF
+11.84%
$12.35
BMNR
+6.05%
$32.82
LNW
-3.71%
$86.22
AAL
+0.45%
$12.39
ADD
-25.47%
$0.05
PFE
+1.53%
$25.46
AMZN
-3.94%
$223.69
AMD
-3.42%
$232.28
CAN
+18.99%
$1.01
NOK
-0.30%
$6.64
SRM
+53.27%
$10.30
GOOGL
+1.24%
$288.58
KXIN
+3.27%
$0.29
GPUS
+1.21%
$0.24
TLRY
-0.48%
$1.02
BURU
-3.94%
$0.20
ABEV
+0.02%
$2.54
HIMS
-3.78%
$35.58
RIG
+1.34%
$4.13
QBTS
-3.30%
$22.83
RUBI
+0.34%
$0.17
LFS
+55.05%
$5.98
RGTI
+3.58%
$25.57
WLGS
-5.57%
$0.04
IREN
+5.18%
$49.87
ONFO
+9.64%
$0.93
MTSR
-0.35%
$70.50
TWOH
+4.16%
$0.00
PLTD
+0.97%
$7.02
BYND
0.00%
$1.04
CRWV
+2.24%
$77.01
APLT
+2.28%
$0.29
NFLX
+3.69%
$114.36
KVUE
+0.15%
$16.26
T
+0.92%
$25.70
GRAB
-0.09%
$5.32
CGTL
-10.94%
$0.72
RIVN
+0.77%
$14.98
AAPL
+0.28%
$268.22
MU
-3.74%
$232.89
IONZ
-8.73%
$4.60
BTG
+0.27%
$4.00
EPSM
+96.22%
$2.78
AFMD
-34.94%
$0.18
BMNU
+11.98%
$8.78
CLF
+3.87%
$11.39
BBD
+0.13%
$3.62
DVLT
-4.82%
$1.77
HOOD
-0.72%
$115.13
GLMD
+1.90%
$1.07
MSFT
-2.51%
$494.70
SOUN
+1.35%
$11.58
BTBT
+4.31%
$2.39
QS
+1.51%
$13.14
YMM
-11.93%
$10.85
PLTZ
+2.14%
$7.25
MRK
+4.16%
$96.73
GOOG
+0.89%
$288.16
PR
+0.36%
$13.68
BTE
+3.48%
$3.12
VALE
+0.56%
$12.23
HPE
+0.33%
$21.30
RXRX
+1.69%
$4.18
HPQ
-6.76%
$22.87
NBIS
+7.72%
$92.62
RR
+4.34%
$3.25
AMC
+1.61%
$2.20
KDLY
-9.91%
$0.55
CLSK
+4.14%
$11.05
BAC
+0.83%
$51.91
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.